Saturday - December 13, 2025

Category Archives: Pharmaceuticals & Biotech

Alcohol Use Disorder Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Alcohol Use Disorder Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Alcohol Use Disorder pipeline landscape. It covers the Alcohol Use Disorder pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Duchenne Muscular Dystrophy Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight

DelveInsight’s “Duchenne Muscular Dystrophy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Schizophrenia Clinical Trial Pipeline Accelerates as 55+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Schizophrenia Pipeline Insight 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in the Schizophrenia pipeline landscape. It covers the Schizophrenia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Schizophrenia Pipeline … Continue reading →

Peanut Allergy Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Peanut Allergy Pipeline Insight, 2025” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Peanut Allergy pipeline landscape. It covers the Peanut Allergy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Traumatic Brain Injury Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | SanBio, Oxeia Biopharmaceuticals, Oragenics, Hope Biosciences, SHINKEI Therapeutics, VeriNO

The Key Traumatic Brain Injury Companies in the market include – SanBio, Oxeia Biopharmaceuticals, Oragenics, Hope Biosciences, SHINKEI Therapeutics, VeriNOS Pharmaceuticals GmbH, Cellvation, Inc., Abalonex, LLC, The SanBio Group, Hope Biosciences, CereMark Pharma, LLC, Hamad Medical Corporation, Supernus Pharmaceuticals, Inc., … Continue reading →

IgG4-related Disease Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Zenas BioPharma, Horizon Therapeutics, Amgen, Sanofi, UMC Utrecht

The Key IgG4-related Disease Companies in the market include – Zenas BioPharma, Horizon Therapeutics, Amgen, Sanofi, UMC Utrecht, and others.   DelveInsight’s “IgG4-related Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the IgG4-related Disease, historical … Continue reading →

Hashimoto’s Thyroiditis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | TNF Pharmaceuticals, Sling Therapeutics

The Key Hashimoto’s Thyroiditis Companies in the market include – TNF Pharmaceuticals, Sling Therapeutics, and others.   DelveInsight’s “Hashimoto’s Thyroiditis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Hashimoto’s Thyroiditis, historical and forecasted epidemiology as … Continue reading →

Paroxysmal Nocturnal Hemoglobinuria Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Alexion Pharma, Hoffmann-La Roche, Novartis, Regeneron Pharma, AKARI Therapeut

The Key Paroxysmal Nocturnal Hemoglobinuria Companies in the market include – Hoffmann-La Roche (Chugai Pharmaceutical), AstraZeneca (Alexion Pharmaceuticals), Apellis Pharmaceuticals, Swedish Orphan Biovitrum, Regeneron, Pharmaceuticals, Alnylam Pharmaceuticals, Omeros Corporation, BioCryst Pharmaceuticals, Novartis, Chengdu Suncadia Medicine Co., Ltd., Wuhan Createrna Science, … Continue reading →

Postpartum Depression Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | SAGE Therapeutics, Brii Biosciences Limited, Reunion Neuroscience, GH Research, Bristol-Myers

The Key Postpartum Depression Companies in the market include – SAGE Therapeutics, Brii Biosciences Limited, Reunion Neuroscience, GH Research, Bristol-Myers Squibb, and others.   DelveInsight’s “Postpartum Depression Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the … Continue reading →

Breast Cancer Clinical Trial Pipeline Gains Momentum: 250+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Breast Cancer Pipeline Insight 2025” report provides comprehensive insights about 250+ Breast Cancer companies and 300+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It … Continue reading →